DRI vs EDIT
Darden Restaurants Inc (DRI) versus Editas Medicine Inc (EDIT) — a side-by-side from cached financials, not a winner call.
Darden Restaurants Inc (DRI) is a restaurants company listed on NYSE.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Latest reported DRI revenue for 2025-05-25 was $12.08B. Net income was $1.05B. Revenue was up 6.0% from 2024-05-26 to 2025-05-25. DRI currently screens at market cap $24.20B and trailing P/E 22.3.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
DRI currently screens at market cap $24.20B and trailing P/E 22.3. EDIT currently screens at market cap $375.2M.
Not investment advice. Open the DRI and EDIT stock pages for the full models.
Not investment advice.